Market conditions remain tough, which is weighing on demand for both Schrödinger's software and drug discovery services. Investors continue to punish Schrödinger's investments in drug discovery, ...

Schrodinger reported strong Q4 2023 results, but weak guidance for 2024, causing a significant drop in the share price. The demand environment continues to impact the software business, with growth ...

Schrodinger (NASDAQ: SDGR) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a research collaboration and license agreement with Novartis to advance multiple development candidates into Novartis’s ...

Schrödinger partners with Novartis for advanced computational drug discovery. Q3 revenue rose 10% in software, though total revenue missed; Schrödinger revised 2024 software guidance. Schrödinger to ...

Goldman Sachs initiated coverage of Schrodinger (SDGR) with a Neutral rating and $19 price target The company’s software business serves as the ...

Research teams can spend nearly a decade looking for new biological targets, but Schrödinger software is helping researchers drastically decrease those timelines by turning to Amazon Web Services.

Mr. Aklian joins Schrödinger from Certara, where he served as senior vice president, global software sales. In this role, Mr. Aklian led a global team of professionals in sales and operations and ...

Schrödinger, a little-known software company that helps some of the largest pharmaceutical brands with drug discovery, made its public debut. The company closed its initial public offering on Monday, ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced financial results ...

This drug discovery company's stock just took a major hit. Amid wild stock price swings, many wonder if they will be catching a falling knife if they buy shares now. Is Schrodinger a safe investment ...